HIGHLIGHTS
- who: Emiliano Montalesi et al. from the Department of Science, University Roma Tre, Vle Marconi, , Rome, Italy have published the research: Resveratrol Analogs and Prodrugs Differently Affect the Survival of Breast Cancer Cells Impairing Estrogen/Estrogen Receptor /Neuroglobin Pathway, in the Journal: (JOURNAL) of 16/Dec/2022
- what: In the present study, four different RSV analogs were developed and their effects on ERu03b1/NGB pathway were compared with RSV-conjugated gold nanospheres as a prodrug to evaluate if RSV derivatives maintain breast cancer cell susceptibility to the chemotherapeutic drug paclitaxel as the non-conjugated compound . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.